Research by Guccini et al. showed that genetic deletion of the metabolic enzyme KHK-C, by inhibiting the KRAS-MAPK and mTORC signaling pathways, suppresses the development of pancreatic cancer, suggesting that KHK-C typically promotes the survival and proliferation of pancreatic cancer cells 160. The gene discussed is KRAS; the disease is pancreatic neoplasm.